|  | Mediators |  |
---|---|---|---|
Leg fatigue | Dyspnea | Joint mediator | |
Simulation-based approacha | Â | Â | Â |
  TE, m (95% CI) | 81.4 (55.2–109.4) | 82.3 (57.4–110.3) | 82.1 (56.7–112.6) |
  NDE, m (95% CI) | 47.1 (4.6–85.2) | 9.8 (-32.9–49.9) | -5.8 (-55.4–43.9) |
  NIE, m (95% CI) | 34.3 (-2.1–82.1) | 72.5 (31.3–121.0) | 88.9 (32.7–148.5) |
  PM, % | 42.1 | 88.1 | 107.0 |
Sensitivity analyses | Â | Â | Â |
 Addition of covariatesb |  |  |  |
  TE, m (95% CI) | 82.8 (53.7–113.1) | 83.3 (54.1–112.9) | 84.1 (54.1–114.1) |
  NDE, m (95% CI) | 49.4 (4.8–89.4) | 11.1 (-34.7–53.9) | -5.2 (-59.3–45.5) |
  NIE, m (95% CI) | 33.5 (-3.7–81.8) | 72.2 (25.4–123.6) | 89.3 (33.7–152.9) |
  PM, % | 40.4 | 86.7 | 106.2 |
 Weighting approacha |  |  |  |
  TE, m (95% CI) | 80.8 (58.1–105.3) | 80.8 (58.1–105.3) | 80.8 (58.1–105.3) |
  NDE, m (95% CI) | 50.8 (6.7–89.1) | 9.5 (-35.8–49.9) | -7.0 (-58.7–44.0) |
  NIE, m (95% CI) | 29.9 (-6.1–75.5) | 71.3 (30.4–120.8) | 87.8 (31.5–146.9) |
  PM, % | 37.1 | 88.3 | 108.6 |